Lambo, Rogelio T.
HRN: 10-66-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/16/2025
11/23/2025
IV
2.25g
Q6
PMBO
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: No Wrong Dose
Overall appropriateness: No Adjust Dose According To EGFR